Learn how an Access Fabric can continuously decide who can access what, from where, and under what conditions—in real time.

In case you missed it (somehow), agents were recently revealed as the next big step forward with AI in Windows 11, and ...

The Center for Biosimilars connects professionals with insights on biosimilars, health economics, regulatory outcomes, and ...

Tolebrutinib was one of three oral BTK inhibitors that Sanofi acquired as part of its $3.7 billion buyout of Principia ...

Microsoft has good news for administrators: while some organizations now pay for security updates on older Windows versions, ...

Cybercriminals have quietly turned a small, easy-to-miss mistake into a highly effective way to drain Microsoft accounts, ...

Tolebrutinib, which Sanofi acquired in a $3.7 billion buyout, failed a Phase 3 study in “primary progressive” multiple ...

OpenAI and Microsoft formalized a restructured partnership in October 2025, transitioning OpenAI to a for-profit public ...

Sanofi will not be pursuing approval of tolebrutinib for PPMS, and an FDA decision on the therapy in nonrelapsing SPMS will ...

The move aims to expand the use of Security Copilot and comes with the launch of 12 new agents from Microsoft at the company's Ignite conference last week.

Microsoft (NASDAQ:MSFT) supports enterprise productivity and collaboration as nasdaq index discussions highlight major ...

Copilot may be the least respected AI in Big Tech, but Microsoft AI chief Mustafa Suleyman continues to impress.